Insider Trading › SRRK › Insiders
Scholar Rock Holding Corp
SRRK·Nasdaq·
United States·Insider activity
$48.13
-2.24 (-4.45%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
SRRK
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SRRKS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, SRRK insiders filed 6 purchases ($12.0M) and 13 sales ($923K) on the open market, by 6 insiders. Newest filing Oct 27, 2026 (25 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by SRRK insiders · Form 4 · last two years
On Record
$12.0MPurchases · 180 days
$923KSales · 180 days
193Open-market transactions on record
6Insiders filing · 180 days
Purchases (code P) and sales (code S) of SRRK common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
193 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVASDirector · Director | Purchase | +98.0K | $41.59 | $4.1M | 723.0Kindirect | Oct 26, 2026 | Oct 27, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +49.0K | $41.59 | $2.0M | 6.4Mindirect | Oct 26, 2026 | Oct 27, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +94.0K | $41.31 | $3.9M | 624.0Kindirect | Oct 23, 2026 | Oct 27, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +500 | $41.82 | $21K | 6.3Mindirect | Oct 23, 2026 | Oct 27, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +47.0K | $41.31 | $1.9M | 6.3Mindirect | Oct 23, 2026 | Oct 27, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +1,000 | $41.82 | $42K | 625.0Kindirect | Oct 23, 2026 | Oct 27, 2026 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −15 | $54.88 | $823 | 27.9Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −1,470 | $54.24 | $80K | 27.9Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −1,568 | $53.53 | $84K | 29.3Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −43 | $54.81 | $2K | 59.5Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −1,155 | $54.23 | $63K | 59.6Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −1,346 | $53.54 | $72K | 60.7Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Burow KristinaDirector | Sale | −948 | $54.28 | $51K | 114.7Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Burow KristinaDirector | Sale | −2,105 | $53.49 | $113K | 115.6Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Reed JoshuaDirector | Sale | −948 | $54.28 | $51K | 19.5Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Reed JoshuaDirector | Sale | −2,105 | $53.50 | $113K | 20.5Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Peng KatieDirector | Sale | −21 | $54.96 | $1K | 34.3Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Peng KatieDirector | Sale | −2,437 | $54.25 | $132K | 34.3Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Peng KatieDirector | Sale | −2,988 | $53.56 | $160K | 36.8Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Woods KeithChief Operating Officer | Sale | −10.2K | $49.57 | $507K | 620.1Kdirect | Apr 16, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Vaishnaw AkshayPresident of R&D · Director | Sale | −12.2K | $49.57 | $607K | 630.5Kdirect | Apr 16, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Sinha VikasChief Financial Officer | Sale | −10.4K | $49.57 | $516K | 619.9Kdirect | Apr 16, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Hallal DavidChief Executive Officer · Director | Sale | −30.6K | $49.57 | $1.5M | 1.6Mdirect | Apr 16, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −200 | $48.48 | $10K | 98.4Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −857 | $47.86 | $41K | 98.6Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −7,427 | $46.94 | $349K | 99.5Kdirect | Feb 23, 2026 | Feb 25, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −7,989 | $46.53 | $372K | 106.9Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −9,035 | $46.53 | $420K | 169.1Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −9,580 | $46.53 | $446K | 241.5Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −4,157 | $46.53 | $193K | 126.0Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −12.8K | $46.85 | $599K | 85.7Kdirect | Jan 22, 2026 | Jan 23, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −2,119 | $45.87 | $97K | 98.4Kdirect | Jan 22, 2026 | Jan 23, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −8,406 | $44.48 | $374K | 100.6Kdirect | Jan 16, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −6,600 | $44.48 | $294K | 148.9Kdirect | Jan 16, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −8,016 | $44.48 | $357K | 214.6Kdirect | Jan 16, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −5,798 | $44.48 | $258K | 95.7Kdirect | Jan 16, 2026 | Jan 21, 2026 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −13.1K | $45.20 | $593K | 109.0Kdirect | Jan 14, 2026 | Jan 16, 2026 | Form 4 ↗ |
| Sinha VikasChief Financial Officer | Sale | −16.8K | $42.70 | $715K | 583.2Kdirect | Jan 13, 2026 | Jan 15, 2026 | Form 4 ↗ |
| Woods KeithChief Operating Officer | Sale | −16.7K | $42.70 | $715K | 583.3Kdirect | Jan 13, 2026 | Jan 15, 2026 | Form 4 ↗ |
| Vaishnaw AkshayPresident of R&D · Director | Sale | −20.4K | $42.70 | $873K | 595.8Kdirect | Jan 13, 2026 | Jan 15, 2026 | Form 4 ↗ |
| Hallal DavidChief Executive Officer · Director | Sale | −57.5K | $42.70 | $2.5M | 1.5Mdirect | Jan 13, 2026 | Jan 15, 2026 | Form 4 ↗ |
| Peng KatieDirector | Sale | −280 | $44.63 | $12K | 32.9Kdirect | Dec 16, 2025 | Dec 18, 2025 | Form 4 ↗ |
| Peng KatieDirector | Sale | −726 | $43.88 | $32K | 33.2Kdirect | Dec 16, 2025 | Dec 18, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −136.5K | $45.21 | $6.2M | 109.0Kdirect | Dec 4, 2025 | Dec 5, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +4,403 | $40.97 | $180K | 530.0Kindirect | Oct 7, 2025 | Dec 16, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +12.4K | $40.18 | $498K | 525.6Kindirect | Oct 7, 2025 | Dec 16, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +12.8K | $39.31 | $503K | 513.2Kindirect | Oct 7, 2025 | Dec 16, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +13.7K | $39.52 | $543K | 500.4Kindirect | Oct 6, 2025 | Oct 7, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +80.9K | $38.68 | $3.1M | 486.7Kindirect | Oct 6, 2025 | Oct 7, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +18.4K | $37.89 | $698K | 405.8Kindirect | Oct 6, 2025 | Oct 7, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +319.7K | $37.42 | $12.0M | 387.4Kindirect | Oct 3, 2025 | Oct 7, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +56.7K | $36.74 | $2.1M | 67.7Kindirect | Oct 3, 2025 | Oct 7, 2025 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Purchase | +11.0K | $35.61 | $392K | 11.0Kindirect | Oct 3, 2025 | Oct 7, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −3,353 | $30.67 | $103K | 109.0Kdirect | Sep 22, 2025 | Sep 24, 2025 | Form 4 ↗ |
| Peng KatieDirector | Sale | −76 | $33.20 | $3K | 33.9Kdirect | Sep 16, 2025 | Sep 17, 2025 | Form 4 ↗ |
| Peng KatieDirector | Sale | −930 | $32.48 | $30K | 34.0Kdirect | Sep 16, 2025 | Sep 17, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −3,178 | $33.52 | $107K | 112.3Kdirect | Sep 16, 2025 | Sep 17, 2025 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −2,178 | $31.17 | $68K | 155.5Kdirect | Aug 18, 2025 | Aug 19, 2025 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −11.1K | $40.02 | $446K | 0indirect | Jul 16, 2025 | Jul 18, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −24.1K | $34.44 | $829K | 115.5Kdirect | Jul 8, 2025 | Jul 10, 2025 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −11.1K | $33.21 | $370K | 11.1Kindirect | Jun 23, 2025 | Jun 25, 2025 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −2,766 | $32.74 | $91K | 24.1Kdirect | Jun 23, 2025 | Jun 25, 2025 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −17.6K | $32.16 | $564K | 26.8Kdirect | Jun 23, 2025 | Jun 25, 2025 | Form 4 ↗ |
| Peng KatieDirector | Sale | −54 | $32.53 | $2K | 34.9Kdirect | Jun 16, 2025 | Jun 17, 2025 | Form 4 ↗ |
| Peng KatieDirector | Sale | −2,977 | $31.96 | $95K | 35.0Kdirect | Jun 16, 2025 | Jun 17, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −3,668 | $32.00 | $117K | 139.6Kdirect | Jun 16, 2025 | Jun 17, 2025 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −6,186 | $32.00 | $198K | 157.6Kdirect | Jun 16, 2025 | Jun 17, 2025 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −7,442 | $32.00 | $238K | 222.6Kdirect | Jun 16, 2025 | Jun 17, 2025 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −4,975 | $29.84 | $148K | 24.1Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −1,100 | $29.23 | $32K | 29.0Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Burow KristinaDirector | Sale | −4,400 | $29.83 | $131K | 21.1Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Burow KristinaDirector | Sale | −1,000 | $29.24 | $29K | 25.5Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −2,745 | $29.83 | $82K | 55.2Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −630 | $29.22 | $18K | 58.0Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Brudnick RichardDirector | Sale | −1,400 | $30.00 | $42K | 15.1Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Brudnick RichardDirector | Sale | −4,675 | $29.63 | $139K | 16.5Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Reed JoshuaDirector | Sale | −500 | $30.04 | $15K | 15.7Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Reed JoshuaDirector | Sale | −4,900 | $29.68 | $145K | 16.2Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Vaishnaw AkshayPresident of R&D · Director | Sale | −1,620 | $30.01 | $49K | 616.2Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Vaishnaw AkshayPresident of R&D · Director | Sale | −5,130 | $29.63 | $152K | 617.8Kdirect | May 29, 2025 | May 30, 2025 | Form 4 ↗ |
| Sacco TraceyChief Commercial Officer | Sale | −84 | $33.49 | $3K | 71.8Kdirect | Apr 25, 2025 | Apr 29, 2025 | Form 4 ↗ |
| Sacco TraceyChief Commercial Officer | Sale | −4,916 | $32.81 | $161K | 71.8Kdirect | Apr 25, 2025 | Apr 29, 2025 | Form 4 ↗ |
| Sacco TraceyChief Commercial Officer | Sale | −5,000 | $32.89 | $164K | 71.8Kdirect | Mar 24, 2025 | Mar 25, 2025 | Form 4 ↗ |
| Sacco TraceyChief Commercial Officer | Sale | −1,500 | $33.70 | $51K | 76.8Kdirect | Mar 24, 2025 | Mar 25, 2025 | Form 4 ↗ |
| Moore ErinInterim PFO and PAO | Sale | −13.6K | $33.12 | $449K | 82.6Kdirect | Mar 24, 2025 | Mar 25, 2025 | Form 4 ↗ |
| Peng KatieDirector | Sale | −1,006 | $34.42 | $35K | 30.3Kdirect | Mar 17, 2025 | Mar 19, 2025 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −29.4K | $34.87 | $1.0M | 111.3Kdirect | Mar 10, 2025 | Mar 12, 2025 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −112.9K | $35.82 | $4.0M | 140.7Kdirect | Mar 10, 2025 | Mar 12, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −20.2K | $37.74 | $762K | 111.1Kdirect | Feb 19, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −8,341 | $37.56 | $313K | 131.3Kdirect | Feb 19, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −40.0K | $37.20 | $1.5M | 139.6Kdirect | Feb 19, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −4,135 | $36.83 | $152K | 131.3Kdirect | Feb 18, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −5,296 | $36.83 | $195K | 140.3Kdirect | Feb 18, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −7,809 | $36.83 | $288K | 140.7Kdirect | Feb 18, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −5,742 | $36.83 | $211K | 189.3Kdirect | Feb 18, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Backstrom Jay T.CHIEF EXECUTIVE OFFICER · Director | Sale | −18.4K | $36.83 | $677K | 312.0Kdirect | Feb 18, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Backstrom Jay T.CHIEF EXECUTIVE OFFICER · Director | Sale | −22.3K | $44.20 | $986K | 330.4Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −5,655 | $44.20 | $250K | 67.2Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Sacco TraceyChief Commercial Officer | Sale | −3,890 | $44.20 | $172K | 45.4Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −7,347 | $44.20 | $325K | 135.4Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −6,434 | $44.20 | $284K | 145.6Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −12.5K | $44.20 | $554K | 148.5Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −9,039 | $44.20 | $400K | 195.0Kdirect | Jan 16, 2025 | Jan 21, 2025 | Form 4 ↗ |
| Invus Global Management, LLC10% owner | Sale | −1.6M | $41.65 | $66.6M | 9.3Mdirect | Dec 10, 2024 | Dec 12, 2024 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Sale | −149 | $40.98 | $6K | 10.9Mdirect | Nov 25, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Sale | −30.7K | $40.14 | $1.2M | 10.9Mdirect | Nov 25, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Sale | −126.4K | $39.51 | $5.0M | 10.9Mdirect | Nov 25, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Sale | −43.9K | $38.43 | $1.7M | 11.0Mdirect | Nov 25, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Sale | −208.3K | $37.63 | $7.8M | 11.1Mdirect | Nov 25, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −200 | $40.72 | $8K | 72.9Kdirect | Nov 25, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −3,075 | $39.93 | $123K | 73.1Kdirect | Nov 25, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −2,100 | $39.25 | $82K | 76.1Kdirect | Nov 25, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −1,000 | $38.04 | $38K | 78.2Kdirect | Nov 25, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −2,145 | $30.01 | $64K | 72.9Kdirect | Nov 22, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −2,105 | $30.00 | $63K | 72.9Kdirect | Nov 11, 2024 | Nov 13, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −37.2K | $34.90 | $1.3M | 161.1Kdirect | Oct 8, 2024 | Oct 10, 2024 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Sale | −155.7K | $32.50 | $5.1M | 5.6Mindirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Sale | −510.0K | $30.00 | $15.3M | 5.8Mindirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector | Sale | −510.0K | $27.50 | $14.0M | 6.3Mindirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −31.3K | $29.05 | $908K | 161.1Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −25.8K | $27.27 | $704K | 192.3Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −37.2K | $26.83 | $998K | 218.2Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −112.0K | $25.61 | $2.9M | 255.4Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Sacco TraceyCHIEF COMMERCIAL OFFICER | Sale | −1,964 | $26.23 | $52K | 49.3Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Sacco TraceyCHIEF COMMERCIAL OFFICER | Sale | −28.0K | $25.58 | $717K | 51.2Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −39.4K | $30.06 | $1.2M | 72.9Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −2,552 | $26.22 | $67K | 112.2Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | −67.4K | $25.59 | $1.7M | 114.8Kdirect | Oct 7, 2024 | Oct 7, 2024 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −1,936 | $8.58 | $17K | 142.8Kdirect | Sep 16, 2024 | Sep 19, 2024 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −1,451 | $9.33 | $14K | 152.0Kdirect | Aug 16, 2024 | Aug 19, 2024 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −2,315 | $8.99 | $21K | 144.7Kdirect | Jun 17, 2024 | Jun 18, 2024 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −4,305 | $8.98 | $39K | 153.4Kdirect | Jun 17, 2024 | Jun 18, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −9,458 | $8.98 | $85K | 201.5Kdirect | Jun 17, 2024 | Jun 18, 2024 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −4,695 | $8.98 | $42K | 204.1Kdirect | Jun 17, 2024 | Jun 18, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −4,744 | $15.74 | $75K | 211.0Kdirect | Feb 16, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | −2,512 | $15.74 | $40K | 147.0Kdirect | Feb 16, 2024 | Feb 20, 2024 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −3,751 | $15.74 | $59K | 157.7Kdirect | Feb 16, 2024 | Feb 20, 2024 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −3,489 | $15.74 | $55K | 208.8Kdirect | Feb 16, 2024 | Feb 20, 2024 | Form 4 ↗ |
| Backstrom Jay T.CHIEF EXECUTIVE OFFICER · Director | Sale | −11.6K | $15.74 | $183K | 352.7Kdirect | Feb 16, 2024 | Feb 20, 2024 | Form 4 ↗ |
| Qatanani MoSVP AND HEAD OF RESEARCH | Sale | −2,002 | $15.93 | $32K | 78.8Kdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −2,849 | $15.93 | $45K | 114.3Kdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −6,634 | $15.93 | $106K | 162.2Kdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Ho JunlinGENERAL COUNSEL | Sale | −4,186 | $15.93 | $67K | 154.4Kdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −300 | $19.51 | $6K | 168.8Kdirect | Dec 29, 2023 | Dec 29, 2023 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −12.2K | $18.82 | $229K | 169.1Kdirect | Dec 29, 2023 | Dec 29, 2023 | Form 4 ↗ |
| Qatanani MoSVP AND HEAD OF RESEARCH | Sale | −24.7K | $18.18 | $448K | 80.8Kdirect | Dec 14, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −24.9K | $17.53 | $437K | 168.8Kdirect | Dec 7, 2023 | Dec 8, 2023 | Form 4 ↗ |
| Myles Edward HCOO & CFO | Sale | −35.0K | $12.51 | $438K | 168.8Kdirect | Nov 2, 2023 | Nov 3, 2023 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · 10% owner | Purchase | +2.2M | $6.85 | $15.0M | 6.8Mindirect | Oct 16, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Samsara BioCapital GP, LLC10% owner | Purchase | +2.2M | $6.85 | $15.0M | 6.8Mindirect | Oct 16, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Wittouck Amaury10% owner | Purchase | +10.2K | $8.55 | $87K | 11.3Mdirect | Oct 12, 2023 | Oct 16, 2023 | Form 4 ↗ |
| Wittouck Amaury10% owner | Purchase | +2.2M | $6.85 | $15.0M | 11.2Mdirect | Oct 12, 2023 | Oct 16, 2023 | Form 4 ↗ |
| Qatanani MoSVP AND HEAD OF RESEARCH | Sale | −1,945 | $6.34 | $12K | 97.0Kdirect | Sep 18, 2023 | Sep 20, 2023 | Form 4 ↗ |
| Parlavecchio CarynCHRO | Sale | −1,353 | $6.83 | $9K | 117.2Kdirect | Aug 16, 2023 | Aug 18, 2023 | Form 4 ↗ |
| Artal International Management S.A.10% owner | Purchase | +31.6K | $6.43 | $203K | 9.1Mdirect | Apr 28, 2023 | May 2, 2023 | Form 4 ↗ |
| Artal Group S.A.10% owner | Sale | −1,094 | $9.48 | $10K | 9.0Mdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Artal Group S.A.10% owner | Purchase | +48.8K | $9.33 | $455K | 9.0Mdirect | Jan 5, 2023 | Jan 9, 2023 | Form 4 ↗ |
| Stichting Administratiekantoor Westend10% owner | Purchase | +130.3K | $8.04 | $1.0M | 9.0Mdirect | Oct 25, 2022 | Oct 27, 2022 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Purchase | +66.0K | $7.89 | $521K | 8.9Mdirect | Oct 4, 2022 | Oct 7, 2022 | Form 4 ↗ |
| Invus Public Equities Advisors, LLC10% owner | Purchase | +34.0K | $7.03 | $239K | 8.8Mdirect | Oct 3, 2022 | Oct 7, 2022 | Form 4 ↗ |
| Nashat AmirDirector | Purchase | +66.1K | $4.90 | $324K | 206.9Kindirect | Jun 22, 2022 | Jun 24, 2022 | Form 4 ↗ |
| Nashat AmirDirector | Purchase | +1.1M | $4.90 | $5.5M | 3.5Mindirect | Jun 22, 2022 | Jun 24, 2022 | Form 4 ↗ |
| Myles Edward HChief Financial Officer | Sale | −4,879 | $35.05 | $171K | 24.1Kdirect | Nov 15, 2021 | Nov 15, 2021 | Form 4 ↗ |
| Myles Edward HChief Financial Officer | Sale | −49.8K | $35.12 | $1.8M | 24.1Kdirect | Nov 12, 2021 | Nov 15, 2021 | Form 4 ↗ |
| Myles Edward HChief Financial Officer | Sale | −23.6K | $35.20 | $830K | 24.1Kdirect | Nov 11, 2021 | Nov 15, 2021 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −6,000 | $30.89 | $185K | 22.3Kindirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −500 | $34.09 | $17K | 9,013direct | Sep 20, 2021 | Sep 21, 2021 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −3,037 | $31.48 | $96K | 28.3Kindirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| FLIER JEFFREY S.Director | Sale | −2,963 | $31.84 | $94K | 31.3Kindirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −4,696 | $65.59 | $308K | 37.5Kdirect | Mar 15, 2021 | Mar 17, 2021 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −1,804 | $65.06 | $117K | 42.2Kdirect | Feb 8, 2021 | Feb 11, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale Amended | −1,561 | $57.79 | $90K | 32.7Kdirect | Jan 27, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale Amended | −12.1K | $56.72 | $689K | 34.3Kdirect | Jan 27, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale Amended | −5,400 | $55.87 | $302K | 46.4Kdirect | Jan 27, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −1,561 | $57.79 | $90K | 26.9Kdirect | Jan 27, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −12.1K | $56.72 | $689K | 28.4Kdirect | Jan 27, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −5,400 | $55.87 | $302K | 40.6Kdirect | Jan 27, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale Amended | −1,064 | $61.52 | $65K | 51.8Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale Amended | −2,543 | $60.65 | $154K | 52.9Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −1,518 | $59.90 | $91K | 44.0Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −1,500 | $59.02 | $89K | 45.5Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Gilman MichaelDirector | Sale | −483 | $57.99 | $28K | 47.0Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −1,064 | $61.52 | $65K | 46.0Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −8,417 | $60.65 | $510K | 47.0Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −9,249 | $59.69 | $552K | 55.4Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −13.4K | $58.79 | $786K | 64.7Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Carven Gregory JohnHead of Research | Sale | −4,676 | $57.91 | $271K | 78.1Kdirect | Jan 26, 2021 | Jan 28, 2021 | Form 4 ↗ |
| Polaris Venture Partners VI, L.P.10% owner | Purchase | +7,887 | n/c | — | 156.4Kindirect | May 29, 2018 | May 31, 2018 | Form 4 ↗ |
| Polaris Venture Partners VI, L.P.10% owner | Purchase | +135.0K | n/c | — | 2.7Mindirect | May 29, 2018 | May 31, 2018 | Form 4 ↗ |
| Nashat AmirDirector · 10% owner | Purchase | +7,887 | n/c | — | 156.4Kindirect | May 29, 2018 | May 31, 2018 | Form 4 ↗ |
| Nashat AmirDirector · 10% owner | Purchase | +135.0K | n/c | — | 2.7Mindirect | May 29, 2018 | May 31, 2018 | Form 4 ↗ |
| Artal Group S.A.10% owner | Purchase | +450.0K | n/c | — | 450.0Kindirect | May 29, 2018 | May 31, 2018 | Form 4 ↗ |
| SPRINGER TIMOTHY ADirector · 10% owner | Purchase | +71.4K | n/c | — | 3.3Mdirect | May 29, 2018 | May 31, 2018 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Sep 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →
